Holen Sie sich die Stockscreener-App
44.93
3.88%
1.68
Handel nachbörslich:
44.93
Schlusskurs vom Vortag:
$43.25
Offen:
$43.02
24-Stunden-Volumen:
1.07M
Relative Volume:
0.90
Marktkapitalisierung:
$3.59B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-269.44M
KGV:
-11.98
EPS:
-3.75
Netto-Cashflow:
$-262.63M
1W Leistung:
+2.04%
1M Leistung:
-6.94%
6M Leistung:
+2.53%
1J Leistung:
+75.37%
1-Tages-Spanne:
$42.97
$45.09
1-Wochen-Bereich:
$42.55
$45.37
52-Wochen-Spanne:
$21.34
$58.40
Akero Therapeutics Inc Stock (AKRO) Company Profile
Firmenname
Akero Therapeutics Inc
Sektor
Branche
Telefon
650-487-6488
Adresse
601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO, CA
Vergleichen Sie AKRO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AKRO
Akero Therapeutics Inc
|
44.93 | 3.46B | 0 | -269.44M | -262.63M | -3.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.37 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
468.58 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
568.20 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
763.52 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
335.67 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Akero Therapeutics Inc Stock (AKRO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-08-04 | Eingeleitet | TD Cowen | Buy |
| 2025-01-30 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-01-27 | Bestätigt | H.C. Wainwright | Buy |
| 2024-11-18 | Eingeleitet | Citigroup | Buy |
| 2024-04-22 | Fortgesetzt | BofA Securities | Neutral |
| 2023-09-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-08-28 | Eingeleitet | UBS | Buy |
| 2023-01-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-09-14 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-10-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-09-10 | Eingeleitet | BofA Securities | Buy |
| 2021-02-26 | Eingeleitet | Guggenheim | Buy |
| 2020-09-10 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-20 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-07 | Eingeleitet | Chardan Capital Markets | Buy |
| 2020-07-01 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-02-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-07-15 | Eingeleitet | Evercore ISI | Outperform |
| 2019-07-15 | Eingeleitet | JP Morgan | Overweight |
| 2019-07-15 | Eingeleitet | Jefferies | Buy |
| 2019-07-15 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Akero Therapeutics Inc Aktie (AKRO) Neueste Nachrichten
Adage Capital Partners GP L.L.C. Purchases New Shares in Akero Therapeutics, Inc. $AKRO - MarketBeat
PDT Partners LLC Sells 122,183 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
Akero Therapeutics, Inc. $AKRO Shares Acquired by Exome Asset Management LLC - MarketBeat
Akero Therapeutics, Inc. $AKRO Position Decreased by American Century Companies Inc. - MarketBeat
Nomura Holdings Inc. Makes New Investment in Akero Therapeutics, Inc. $AKRO - MarketBeat
What is HC Wainwright's Forecast for AKRO Q1 Earnings? - MarketBeat
Akero therapeutics (AKRO) CSO Rolph sells $552k in stock By Investing.com - Investing.com Canada
200,534 Shares in Akero Therapeutics, Inc. $AKRO Purchased by Eventide Asset Management LLC - MarketBeat
Fred Alger Management LLC Has $20.86 Million Stock Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
Is Akero Therapeutics Inc. a cyclical or defensive stock2025 Sector Review & Technical Entry and Exit Tips - Lancaster City Council
Treasury Yields: Can Akero Therapeutics Inc. maintain its current growth rateTrade Exit Report & Growth Oriented Trading Recommendations - Lancaster City Council
Akero Therapeutics, Inc. $AKRO Shares Sold by Alliancebernstein L.P. - MarketBeat
EcoR1 Capital LLC Takes Position in Akero Therapeutics, Inc. $AKRO - MarketBeat
Cubist Systematic Strategies LLC Has $7.08 Million Position in Akero Therapeutics, Inc. $AKRO - MarketBeat
Akero Therapeutics (NASDAQ:AKRO) Now Covered by HC Wainwright - MarketBeat
Analysts Offer Predictions for AKRO Q3 Earnings - MarketBeat
Quant Models Detect Momentum Reversal in Akero Therapeutics Inc.July 2025 Review & Daily Volume Surge Trade Alerts - beatles.ru
Allostery Investments LP Takes $729,000 Position in Akero Therapeutics, Inc. $AKRO - MarketBeat
Can Akero Therapeutics Inc. disrupt its industryWeekly Profit Analysis & Precise Entry and Exit Recommendations - beatles.ru
What hedge funds are buying Akero Therapeutics Inc.July 2025 Highlights & Capital Efficiency Focused Strategies - beatles.ru
RSI Reset May Fuel Rebound in Akero Therapeutics Inc.Long Setup & Verified Short-Term Plans - beatles.ru
HighTower Advisors LLC Makes New $292,000 Investment in Akero Therapeutics, Inc. $AKRO - MarketBeat
Alkeon Capital Management LLC Lowers Stock Position in Akero Therapeutics, Inc. $AKRO - MarketBeat
Akero Therapeutics, Inc. $AKRO Shares Sold by Baker BROS. Advisors LP - MarketBeat
Redmile Group LLC Has $38.02 Million Stock Position in Akero Therapeutics, Inc. $AKRO - MarketBeat
How does Akero Therapeutics Inc. compare to its peersWeekly Market Report & High Return Trade Opportunity Guides - classian.co.kr
Candlestick signals on Akero Therapeutics Inc. stock todayMarket Rally & Community Verified Watchlist Alerts - Newser
Risk adjusted return profile for Akero Therapeutics Inc. analyzedPortfolio Performance Report & AI Based Trade Execution Alerts - Newser
Analysts Set Akero Therapeutics, Inc. (NASDAQ:AKRO) Target Price at $81.57 - MarketBeat
How cyclical is Akero Therapeutics Inc.’s revenue streamWeekly Market Summary & Real-Time Stock Entry Alerts - خودرو بانک
Is Akero Therapeutics Inc. in a consolidation phaseM&A Rumor & Free High Accuracy Swing Entry Alerts - خودرو بانک
Will Akero Therapeutics Inc. benefit from government policyJuly 2025 Trends & Community Trade Idea Sharing - خودرو بانک
Will Akero Therapeutics Inc. price bounce be sustainableShort Setup & Fast Gain Stock Trading Tips - Newser
Propel Bio Management LLC Sells 114,845 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
Northern Trust Corp Buys 36,412 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
AQST Stock Up as FDA Skips Advisory Meeting to Discuss Anaphylm NDA - sharewise.com
Can Akero Therapeutics Inc. deliver alphaJuly 2025 Short Interest & Accurate Intraday Trading Signals - خودرو بانک
Is Akero Therapeutics Inc. a strong growth stockQuarterly Portfolio Review & Accurate Entry/Exit Alerts - خودرو بانک
How to interpret RSI for Akero Therapeutics Inc. stockQuarterly Portfolio Report & Growth Focused Entry Reports - Newser
Akero Therapeutics, Inc. $AKRO Shares Purchased by Long Focus Capital Management LLC - MarketBeat
Key resistance and support levels for Akero Therapeutics Inc.2025 Buyback Activity & Expert Approved Trade Ideas - Newser
Is Akero Therapeutics Inc. forming a reversal patternMarket Activity Recap & Free Fast Gain Swing Trade Alerts - Newser
Risk vs reward if holding onto Akero Therapeutics Inc.2025 Institutional Moves & Breakout Confirmation Alerts - Newser
Akero therapeutics COO Young sells $576k in shares By Investing.com - Investing.com UK
Akero Therapeutics Stock Doubles on Liver Disease Drug Trial Results - MSN
ADAR1 Capital Management LLC Raises Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
Finanzdaten der Akero Therapeutics Inc-Aktie (AKRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.44%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):